<h4>Background</h4>Serum biomarkers of multiple sclerosis (MS), such as glial fibrillary acidic protein (sGFAP) and neurofilament light chain (sNfL), are established indicators of disease progression and disability. The gene discussed is GFAP; the disease is multiple sclerosis.